Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07854275 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biomarkers, Abdominal Muscle, and Frailty in CKD

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 1 of 1 entry
  2. Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 1 of 1 entry
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In chronic kidney disease (CKD), inflammation and oxidative stress are important processes that may be associated with the development of muscle loss and frailty. The aim of this study is to investigate the relationships between serum MCP-1, total antioxidant status (TAS), and total oxidant status (TOS)-markers of inflammation and oxidative stress-and abdominal muscle thickness and frailty, as assessed by ultrasound, in stage 3-5 CKD patients not receiving dialysis. In addition, the study aims to assess participants' physical performance, kinesiophobia, and quality of life and to examine these characteristics according to CKD stages.
Trial Details
NCT Number NCT07854275
Lead Sponsor Ankara City Hospital Bilkent
Conditions
(from sponsor)		 Chronic Kidney Disease, Abdominal Muscles/Ultrasonography, Frailty
Related terms Frailty, Renal Insufficiency, Chronic
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov